PJWM
ABBV icon

Philip James Wealth Mangement’s AbbVie ABBV Stock Holding History

Philip James Wealth Mangement’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-887
Closed -$203K – 158
2025
Q4 		$203K Buy
887
+4
+0.5% +$911 0.02% 169
2025
Q3 		$205K Buy
+883
New +$180K 0.02% 175

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Philip James Wealth Mangement's ABBV Position: Q1 2026 in Review

Philip James Wealth Mangement sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 887 shares — an estimated $203K sold.

Philip James Wealth Mangement first reported a position in ABBV in Q3 2025 and held it in 2 quarters. The position peaked at $205K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Philip James Wealth Mangement reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Philip James Wealth Mangement sold 887 AbbVie shares in Q1 2026, an estimated $203K.
  • Philip James Wealth Mangement first reported a position in AbbVie in Q3 2025 and held it in 2 quarters.
  • Philip James Wealth Mangement's AbbVie position peaked at $205K in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Philip James Wealth Mangement's 13F filing for Q1 2026, filed 28 Apr 2026.